If daily dialysis is the answer, what is the question?

American Journal of Kidney Diseases

Volumn 37, Issue 4, 2001, Pages 862-865

  Rettig, Richard A ^a  

^a RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DIALYSIS; EDITORIAL; HEALTH CARE FINANCING; HEALTH CARE QUALITY; HUMAN; KIDNEY FAILURE; MEDICARE;

EID: 0035057593     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(01)80138-4     Document Type: Editorial

References (22)

1. The case for daily dialysis: Its impact on costs and quality of life
2. The cost of clinical dialysis - A historical perspective
3. The current and future state of the ESRD program: A provider roundtable
4. Challenges and directions for Medicare ESRD payment policy
5. Evidence-based assessment of medical technology
6. Clinical and biochemical correlates of starting "daily" dialysis
7. A brief history of daily hemodialysis
8. Daily hemodialysis: History and revival of a superior dialysis method
9. Daily hemodialysis. Why the renewed interest?
10. Uneasy alliance - Clinical investigators and the pharmaceutical industry
11. Fair conduct and fair reporting of clinical trials
12. Design issues for clinical trials in acute renal failure
13. Daily hemodialysis: Is it a complex therapy with unproven benefits?
14. Daily hemodialysis is a complex therapy with unproven benefits
15. Cost-effectiveness analysis as a guide to resource allocation in health: Roles and limitations
16. From cost-effectiveness ratios to resource allocation: Where to draw the line?
17. Benefit-cost analysis and public policy implementation: From normative to positive analysis